Remove Bioequivalency Remove Drugs Remove Reagent
article thumbnail

Revised Final Guidance on Nitrosamines Offers New Recommendations for Assessment and Control

FDA Law Blog

Claud — Last week, FDA revised one of its two guidances relating to nitrosamines, Control of Nitrosamine Impurities in Human Drugs. Nitrosamines are impurities that can form during drug manufacturing and are considered potentially potent carcinogens. It’s these varied scenarios that give quality managers nightmares.